NorthWest Biotherapeutics Inc (NWBO): An article about direct-to-consumer phar...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	53
Posts	3430
Boards Moderated	0
Alias Born	10/26/2013

antihama

Re: None

Tuesday, 08/09/2016 7:30:09 AM

Tuesday, August 09, 2016 7:30:09 AM

An article about direct-to-consumer pharmaceutical ads…and about Opdivo in NSCLC.

The overall five-year survival rate for people with Stage 4 lung cancer is between 1 and 5 percent. Instead of a “chance of living longer,” a more truthful narrator would have said, “Opdivo provides an outside chance for people with advanced lung cancer to live just a few months longer.”

We, on this board, realize what the potential of combo therapy w DCVax could do. I hope we get there. I’ll be out of earshot for the rest of the week. It would be nice to have a nice surprise on news when I get back. You can always hope.

http://www.nytimes.com/2016/08/09/opinion/cancer-drug-ads-vs-cancer-drug-reality.html?action=click&pgtype=Homepage&version=Moth-Visible&moduleDetail=inside-nyt-region-4&module=inside-nyt-region®ion=inside-nyt-region&WT.nav=inside-nyt-region